デフォルト表紙
市場調査レポート
商品コード
1008399

行動リハビリテーション市場- 成長、動向、COVID-19の影響、および予測(2021~2026年)

Behavioral Rehabilitation Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 116 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.27円
行動リハビリテーション市場- 成長、動向、COVID-19の影響、および予測(2021~2026年)
出版日: 2021年05月13日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 116 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

行動リハビリテーションの市場規模は、2021年から2026年までの予測期間中に3.5%の安定したCAGRで拡大すると予測されています。

COVID-19のパンデミックは、市場にわずかなマイナスの影響を与えるとみられています。現在、世界中の国々がCOVID-19の深刻な脅威に直面しています。多くの製薬会社やバイオテクノロジー企業は、顧客からの高まる需要に対応するために、消毒製品やワクチンの製造に研究開発活動を集中させています。この状況のために、ほとんどの製薬会社およびバイオテクノロジー企業は、この病気の治療のための新しい分子またはリードを特定することに研究開発部門を集中させてきました。

多くの国がすでにCOVID-19のワクチンを承認しています。たとえば、2020年12月、世界保健機関(WHO)は、Pfizer/BioNTechのCOVID-19mRNAワクチンの緊急使用のためのバリデーションを世界的に発表しました。2021年1月にNature Reviews Neurologyに掲載されたKatya Numbers et al.の調査研究によると、認知症などの精神障害を持つ人々は、認知症状によって保護手順や生活環境の遵守を困難にするため、COVID-19感染のリスクが高いと述べています。介護施設では、ウイルスの拡散を促進します。さらに、認知症の高齢者は、認知症のない人よりも深刻な病気の結果をもたらす可能性が高くなります。Lewy Body Societyによると、認知症および関連障害のある人は、手を洗う、推奨される物理的距離を維持する、COVID-19の症状を監視する、家にいるなど、ウイルスの拡散を防ぐためにつくられた政府のガイドラインに従うのが難しいと述べています。より重度の認知症の人は、短期記憶喪失と認知障害のためにガイドラインを理解または覚えることができない場合があります。英国国家統計局2020によると、認知症とアルツハイマー病は、英国でCOVID-19に関連した死亡者の中で最も一般的な既往症であると報告されています。

さらに、COVID-19のパンデミックにより、多くの家族が大きな経済的負担に直面しており、治療の選択肢を手放す傾向がさらに高まっているとみられています。さらに、パンデミックは新製品の発売にも悪影響を与える可能性があり、これは市場の成長の最も顕著な要因であると推定されています。たとえば、2020年4月、Biogenは、データ分析の複雑さとR&DリソースへのCOVID-19の影響を理由に、アルツハイマー病と認知症薬のFDAへの提出を延期したと発表しました。

当レポートでは、行動リハビリテーション市場について調査し、市場の概要とともに、行動障害タイプ別、医療施設別、治療法別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概要
  • 市場の推進力
    • 罹患率の上昇と行動リハビリテーションの利用可能性
    • オンラインカウンセリングの出現
    • 部分的入院プログラム(PHP)への傾倒
    • 政府のイニシアチブの高まり
  • 市場の抑制要因
    • 行動障害に関する意識の欠如
    • 適切な償還の欠如
    • 行動障害のある人々に対するスティグマの影響
  • ポーターのファイブフォース分析

第5章 市場セグメンテーション

  • 行動障害タイプ別
    • 不安障害
    • 気分障害
    • 薬物乱用障害
    • パーソナリティ障害
    • 注意欠陥障害
  • ヘルスケア施設別
    • 外来患者の行動リハビリテーション
    • 入院患者の行動リハビリテーション
    • 住宅行動リハビリテーション
  • 治療法別
    • カウンセリング
    • 投薬
    • サポートサービス
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 中東とアフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Acadia Healthcare
    • AAC HOLDINGS INC.
    • Aurora Behavioral Health System
    • Behavioral Health Group
    • Haven Behavioral Healthcare Inc.
    • Magellan Health Inc.
    • Niznik Behavioral Health
    • Promises Behavioral Health
    • Springstone Inc.
    • Universal Health Services Inc.
    • CRC Health
    • American Addiction Centers, Inc.

第7章 市場機会と動向

目次
Product Code: 57015

The Behavioral Rehabilitation Market is estimated to grow with a steady CAGR of 3.5 % during the forecast period from 2021-2026.

The COVID-19 pandemic is expected to have a slightly negative impact on the market. At present, countries across the globe are facing a considerable threat of COVID-19 (coronavirus). Many pharmaceutical and biotechnological companies are focusing their R&D activities on manufacturing antiseptic products and vaccines to meet the increased demand from customers. Owing to the situation, most pharmaceutical and biotechnological companies have been focusing their R&D departments on identifying new molecules or leads for the treatment of this disease.​ Many countries have already approved a vaccine for COVID-19. For instance, in December 2020, the World Health Organization (WHO) issued the emergency use validation of Pfizer/BioNTech COVID-19 mRNA vaccine globally. According to a research study by Katya Numbers et al., published in Nature Reviews Neurology in January 2021, stated that people with mental disorders like dementia are at high risk of COVID-19 infection because cognitive symptoms cause difficulty with following safeguarding procedures and living arrangements in care homes facilitate viral spread. Furthermore, older population with dementia are also more likely to have more severe disease consequences than those without dementia. As per Lewy Body Society, stated that people with dementia and related disorders find harder to follow government guidelines designed to prevent the spread of the virus such as washing hands, maintaining the recommended physical distance, monitoring COVID-19 symptoms and staying at home. People with more severe dementia may not be able to understand or remember the guidelines due to their short-term memory loss and cognitive impairment. As per Office for National Statistics UK 2020, stated that dementia and Alzheimer's disease were the most common pre-existing conditions found among deaths involving COVID-19 in United Kingdom.

Furthermore, due to the COVID-19 pandemic, lots of families are facing a significant economic burden, which can lead to an even greater inclination toward letting go of treatment options. Moreover, the pandemic can also have a negative impact on the new product launches, which are estimated to be the most prominent factor of the growth of the market. For instance, in April 2020, Biogen announced that it had delayed Alzheimer's and dementia drug filing to FDA while citing the complexity of data analysis and impact on COVID-19 on its R&D resources

According to the statistics provided by the Mental Health Foundation in 2018, mental health problems were one of the primary causes of rising medical concerns. Furthermore, mental and behavioral health problems are considered to be the primary cause of disability in the age group of 20-29 years, since the past few decades. According to the same source, every year, a large number of people were diagnosed with mental illnesses in the United States. According to the United States Department of Health and Human Services (DHHS) in 2018, one in every five (20%) children and adolescents suffer from mental health disorder at some point in their life. At least, 1 in 10, or about 6 million people suffered serious emotional disturbance at some point in their life.

The treatments for behavioural disorders mainly focuses on behavioural treatment and medication. Parent management training and family therapy are considered quite effective for managing behavioural disorders. Additionally, cognitive behavioral therapy treatment is the most commonly used mechanism for managing the symptoms of behavioral disorders. However, medication treatment for these disorders is targeted toward treating underlying or co-occurring disorders, such as attention deficit hyperactivity disorder (ADHD), depression or anxiety. These developments re expected to positively affect market development.

Key Market Trends

Anxiety Disorder is Expected to Significant Share of the Global Behavioral Rehabilitation Market Over the Forecast Period

The anxiety disorders are different from normal feelings of anxiousness and involve excessive anxiety or fear. According to Our World in Data (OWID), an estimated 284 million people experienced an anxiety disorder in 2017, globally, making it the most prevalent mental health or neurodevelopmental disorder. Whereas, the Anxiety and Depression Association of America (ADAA) states that anxiety disorders are the most common mental illness in the United States, affecting 40 million adults of age 18 and older, i.e., 18.1% of the population each year. Even though anxiety disorders are very much treatable, only 36.9% of those suffering receive treatment, according to the Anxiety and Depression Association of America. Individuals with an anxiety disorder are three to five times more likely to visit the doctor and six times more likely to be hospitalized for psychiatric conditions than those who do not have anxiety disorders. The roots of anxiety disorders are presently unknown but probably involve a combination of factors, including genetic, psychological, environmental, and developmental.

However, many antidepressants, including escitalopram (Lexapro) and fluoxetine (Prozac), can alleviate anxiety disorders and help people lead a normal and productive life. Furthermore, increase in research and development on treatment of anxiety disorders due to overall increasing prevalence of this disorder is expected to drive the market growth over the forecast period.

North America is Expected to Hold the Major Share of the Market Over the Forecast Period

North America is the largest behavioral rehabilitation market in the world, with the United States occupying the major share. The developed countries, including the United States and Canada, have been witnessing a large number of mental health rehabilitation centers opening for the past decade. According to the NIH, in the United States, the prevalence of personality disorder was 9.1%. As per the National Institute of Mental Health, 2018, in the United States, 21.4% of American adults have experienced mood disorders at some point in their lives. It has also been found that there are various new launches in the behavioral health market in North America. For instance, in September 2019, Hackensack Meridian Health launched the first medically integrated urgent care center with behavioral health in the country, with an aim to improve access, better coordinate care, and innovate treatment for people struggling with mental health issues and addiction. Therefore, in addition, favorable government initiatives and a large number of reimbursement options are two of the other factors fueling growth in this region. The Affordable Care Act categorizes behavioral disorders as essential healthcare, which helps in covering the major part of the treatments. Therefore, all these factors affect the growth of the market.

Competitive Landscape

The market is slightly consolidated with a few major players. Currently, many companies are focusing on the development and introduction of novel products and services into the market which is easily affordable and accessible and entering into strategic collaborations and partnerships to enhance their market positions. Some of the key innovations in the market are: In February 2019, Acadia Healthcare acquired the operations and real estate associated with Whittier Pavilion, a premier behavioral healthcare facility located in Haverhill, Massachusetts, and Mission Treatment operates nine comprehensive treatment centers in California, Nevada, Arizona, and Oklahoma.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Prevalence and Availability of Therapies for Behavioral Rehabilitation
    • 4.2.2 Advent of Online Counselling
    • 4.2.3 Increasing Preferences for Partial Hospitalization Programs (PHP)
    • 4.2.4 Rising Government Initiatives
  • 4.3 Market Restraints
    • 4.3.1 Lack of Awareness Regarding Behavioral Disorders
    • 4.3.2 Lack of Proper Reimbursement
    • 4.3.3 Impact of Stigma on People with Behavioral Disorder
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type of Behavioral Disorder
    • 5.1.1 Anxiety Disorder
    • 5.1.2 Mood Disorder
    • 5.1.3 Substance Abuse Disorder
    • 5.1.4 Personality Disorder
    • 5.1.5 Attention Deficit Disorder
  • 5.2 By Healthcare Setting
    • 5.2.1 Outpatient Behavioral Rehabilitation
    • 5.2.2 Inpatient Behavioral Rehabilitation
    • 5.2.3 Residential Behavioral Rehabilitation
  • 5.3 By Treatment Method
    • 5.3.1 Counselling
    • 5.3.2 Medication
    • 5.3.3 Support Services
    • 5.3.4 Other Treatment Methods
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Acadia Healthcare
    • 6.1.2 AAC HOLDINGS INC.
    • 6.1.3 Aurora Behavioral Health System
    • 6.1.4 Behavioral Health Group
    • 6.1.5 Haven Behavioral Healthcare Inc.
    • 6.1.6 Magellan Health Inc.
    • 6.1.7 Niznik Behavioral Health
    • 6.1.8 Promises Behavioral Health
    • 6.1.9 Springstone Inc.
    • 6.1.10 Universal Health Services Inc.
    • 6.1.11 CRC Health
    • 6.1.12 American Addiction Centers, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS